This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page  |  Contact Us  |  Report Abuse  |  Sign In  |  Register
Lp(a) @ AHA
Share |


Dear friend of the foundation,

If you are attending AHA in Anaheim, please join us at booth #1403 in the exhibit hall and bring your colleagues, or encourage them to stop by to find out the latest information on Lp(a). You are our best advocates!

Below, please find a list of sessions and presentations on Lp(a) you might find interesting.  Many of these sessions include members of our clinical and scientific advisory board.  Please join us in supporting these clinicians as they continue to generate awareness for high Lp(a) and it's important role in cardiovascular disease.

If you are one of our social media Lp(a) lovelies, please use the hashtag #TESTLpa when you are posting/tweeting relevant content about Lp(a) from the meeting or retweeting our posts.

We look forward to seeing you at the meeting!


Sessions on Lp(a)

Sunday, November 12th


Session CM.SMP.2505 - Clinical Lipidology Update

Treating Triglycerides and Lp(a): Will Inhibitors of apoCIII, Lp(a) and ANGPTL3 Make the Cut?

Presenter: Joseph Witztum, M.D.

8:44 - 9:06 AM


Session AT.APS.02 - Lipid, Lipoproteins and Atherosclerosis 

ApoB Antisense Treatment Increases the Clearance of Apolipoprotein (a) From Mature Lp(a) Particles S1062

Presenter: Henry Ginsberg, M.D.

11:30 AM


Session LB.APS.01 - Dietary Components and Dietary Interventions for CV Health

Consumption of a Defined Plant Based Diet Reduces Lp(a) and Other Atherogenic Lipoproteins and Particles in Four Weeks S2065

Presenter: Rami S Najjar

11:30 AM


Session EP.APS.05 - Lipids & Lipoproteins 

Extreme Elevations in Both HDL-C and Lp(a), Adiposity, and Subclinical Atherosclerosis in a Multi-ethnic Population-based Cohort: Observation From The Dallas Heart Study

Presenter: Nimish N Shah

3:15 PM

Session CH.CVS.2403 - Ask the Experts: Dilemmas in Pediatric Prevention

Case: 13 year old Male with Stroke, has normal Lipid Profile, No Cardiac Defects and a Lipoprotein(a) level of 410: Clinical Significance of Lp(a) in youth & role if Imaging in Atherosclerosis.

Presenter: Patrick Moriarty, M.D.

4:00 - 4:15 PM

Monday, November 13th 


Session AT.JS.626 - Atherosclerosis Research Update (AHA/Chinese Society of Cardiology Joint Session)

Lp(a) and Atherosclerotic Cardiovascular Disease

Presenter: Sotirios Tsimikas, M.D.

10:55 - 11:05 AM

 Lp(a) Evening CME Symposia






Community Search
Sign In
Login with LinkedIn

Latest News
809 Laurel Street #460
San Carlos, CA 94070